Gastrointestinal effects: Dyspepsia, gastrointestinal bleeding or perforation, peptic ulcer, nausea, diarrhea, abdominal pain, constipation, flatulence, vomiting, anorexia, dry mouth, pancreatitis, gastritis.
Nervous system effects: Headache, insomnia, anxiety, dizziness, malaise, drowsiness, fatigue, paresthesia, asthenia, vertigo.
Hepatic effects: Hepatic dysfunction, elevation of serum SGPT or SGOT concentration.
Hematologic effects: Anemia, purpura, agranulocytosis, thrombocytopenia, neutropenia.
Dermatologic effects: Rash, pruritus, urticaria, photosensitivity reaction, sweating, toxic epidermal necrolysis, Stevens-Johnson syndrome.
Other adverse effects: Dyspnea, bronchospasm, pain, anaphylaxis, visual disturbances, tinnitus, aseptic meningitis.
Inj: Nausea, vomiting, pain at the administration site, anemia, headache, dizziness, insomnia, drowsiness, blurred vision, hypotension, hot flushes, abdominal pain, dyspepsia, diarrhea, constipation, vomiting blood, dry mouth, dermatitis, pruritus, skin rashes, excessive sweating, reaction in injection area, inflammatory bruise or bleeding, fever, fatigue, pain, coldness, hyperglycemia, hypoglycemia, hypertriglyceridemia, paresthesia, tinnitus, extrasystole, tachycardia, hypertension, peripheral edema, thrombophlebitis, superficial, bradypnea, peptic ulcers, bleeding or gastroduodenal perforation, anorexia, elevated liver enzyme, liver disorders, jaundice, urticaria, acne, stiff joints, muscular cramp, polyuria, kidney pain, menstrual disorders, prostatic disorder, back pain, syncope, chills, ketonuria, proteinuria, neutropenia, thrombocytopenia, bronchospasm, dyspnea, pancreatic damage, liver damage, severe mucocutaneous skin reaction (Stevens-Johnson syndrome, Lyell syndrome), angioedema, dermatology reaction, photosensitivity reaction, pruritus, kidney damage (nephritis or nephrotic syndrome), anaphylaxis, face edema.
The following adverse reactions may occur because of the side effects appear in other NSAID and may be related to prostaglandin synthesis inhibitors: Aseptic meningitis: will primarily occur in patients with SLE (Systemic Lupus Erythematosus) or mixed connective tissue disease.
Hematological reactions: purpura, hemolytic and aplastic anemia, and rarely, agranulocytosis and medullar hypoplasia.
View ADR Reporting Link